Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALGS Aligos Therapeutics, Inc.

休市中 10-30 16:00:00 EDT

4.80

-0.23

-4.57%

盘后4.80

+0.000.00%

19:30 EDT

最高5.05	最低4.75	成交量2.38万
今开4.99	昨收5.03	日振幅5.96%
总市值2,997万	流通市值1,767万	总股本624.46万
成交额11.65万	换手率0.65%	流通股本368.17万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALGS","market":"US","secType":"STK","nameCN":"Aligos Therapeutics, Inc.","latestPrice":4.8,"timestamp":1793390400000,"preClose":5.03,"halted":0,"volume":23846,"hourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.8,"latestTime":"19:30 EDT","volume":123,"amount":605.07,"timestamp":1793403002168,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04572564612326052,"floatShares":3681700,"shares":6244600,"eps":-7.301555,"marketStatus":"休市中","change":-0.23,"latestTime":"10-30 16:00:00 EDT","open":4.99,"high":5.05,"low":4.7501,"amount":116504.99835,"amplitude":0.059622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.301555,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793610000000},"marketStatusCode":7,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":5.03,"preHourTrading":{"tag":"盘前","latestPrice":5.03,"preClose":5.03,"latestTime":"07:46 EDT","volume":10,"amount":50.300000000000004,"timestamp":1793360783489,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.8,"latestTime":"19:30 EDT","volume":123,"amount":605.07,"timestamp":1793403002168,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.010166908858271,"impliedVol":0.1576,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ALGS","defaultTab":"news","newsList":[{"id":"1171371738","title":"Aligos Therapeutics宣布：合作伙伴Amoytop在中国启动潜在同类最佳反义寡核苷酸Alg-170675的1期临床首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1171371738","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171371738?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:06","pubTimestamp":1786565174,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics, Inc.（ALGS）今日宣布，其合作伙伴Amoytop已在中国完成了潜在同类最佳反义寡核苷酸Alg-170675的1期临床研究首例受试者给药。这一里程碑标志着该候选药物正式进入人体试验阶段，为后续开发铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ALGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105092086","title":"Aligos Therapeutics获2500万美元首付款，源于大中华区慢性乙型肝炎病毒药物独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1105092086","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105092086?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368416,"startTime":"0","endTime":"0","summary":"专注于慢性乙型肝炎病毒（HBV）感染治疗的生物技术公司Aligos Therapeutics, Inc.，近日宣布已收到一笔高达2500万美元的首付款。这笔款项源自其与合作伙伴就创新药物Pevifoscorvir Sodium（一款针对慢性HBV感染的候选药物）在大中华区达成的独家许可协议。该协议标志着Aligos Therapeutics在拓展关键亚洲市场方面迈出了重要一步，有望为众多慢性乙肝患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220020","title":"Aligos Therapeutics, Inc.盘中异动 早盘急速下挫7.26%报12.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518220020?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Aligos Therapeutics, Inc.股票出现异动，股价快速下挫7.26%。截至发稿，该股报12.00美元/股，成交量2.7267万股，换手率0.76%，振幅3.79%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2096.04%、413.43%、64.56%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213405a26a25ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALGS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169357471","title":"Aligos Therapeutics 第四季度每股收益 $(13.08) 未达预期，销售额 $629.00 千美元 超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1169357471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169357471?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:06","pubTimestamp":1741608360,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics报告季度每股亏损 $，比分析师的共识预期 $ 差 468.7%。公司报告季度销售额为 62.9 万美元，超出分析师共识预期的 43.33 万美元 45.15%。与去年同期销售额 201 万美元相比，这一数据下降了 68.69%。以上内容来自Benzinga Earnings专栏，原文如下：Aligos $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 468.7 percent. This is a 137.82 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $629.00 thousand which beat the analyst consensus estimate of $433.33 t","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166112","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517166112?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271907,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，Aligos Therapeutics, Inc.股票出现波动，股价急速下跌5.48%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1107.94%、213.59%、54.76%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为31.46%、30.53%、23.12%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223828963c4e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516065196","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.02%报16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516065196?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:52","pubTimestamp":1741024325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时52分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报16.02美元/股，成交量4.3923万股，换手率1.22%，振幅6.70%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Alto Neuroscience, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为4294.62%、178.37%、175.13%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040152059637da79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514096332","title":"Aligos Therapeutics, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514096332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:28","pubTimestamp":1740688132,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时28分，Aligos Therapeutics, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报16.85美元/股，成交量14.2729万股，换手率3.98%，振幅9.46%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1927.83%、378.45%、194.99%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228042852a256c99e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","LENZ","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856875","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.31%报18.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856875?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Aligos Therapeutics, Inc.股票出现异动，股价快速上涨5.31%。截至发稿，该股报18.25美元/股，成交量8681股，换手率0.24%，振幅4.53%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Channel Therapeutics Corporation、Immunoprecise Antibodies Ltd.涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为127.32%、94.89%、76.22%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262234569893ab69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514399090","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌6.51%报16.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514399090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514399090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:37","pubTimestamp":1740494235,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时37分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫6.51%。截至发稿，该股报16.66美元/股，成交量8885股，换手率0.25%，振幅3.42%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为793.45%、560.91%、495.53%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Adial Pharmaceuticals, Inc，振幅分别为86.72%、26.11%、20.51%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223715a2538882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513904732","title":"Aligos Therapeutics, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513904732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513904732?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:51","pubTimestamp":1740156706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时51分，Aligos Therapeutics, Inc.股票出现波动，股价大幅下挫5.25%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为231.30%、161.40%、124.05%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222005146988dfcd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALGS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512348185","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报21.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512348185?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:58","pubTimestamp":1739980689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时58分，Aligos Therapeutics, Inc.股票出现异动，股价急速下跌5.05%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为556.97%、241.94%、106.27%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.，振幅分别为207.68%、48.18%、36.97%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219235809abd5107d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512178196","title":"Aligos Therapeutics, Inc.盘中异动 大幅下挫5.03%报22.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512178196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512178196?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:19","pubTimestamp":1739906369,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时19分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。截至发稿，该股报22.48美元/股，成交量9.6674万股，换手率2.69%，振幅7.58%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为845.55%、209.84%、168.60%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031930a24ae823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512529945","title":"在所有治疗领域强劲业绩的推动下，益普生2024年实现稳健业绩增长并确认2025年全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2512529945","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512529945?lang=zh_cn&edition=full","pubTime":"2025-02-17 17:58","pubTimestamp":1739786280,"startTime":"0","endTime":"0","summary":"本年度还与Skyhawk Therapeutics签署了一项合作协议，开发用于治疗罕见神经系统疾病的RNA调节小分子药物。环境、社会和治理 2024年，益普生采取了重要步骤，以实施可持续发展战略的宏伟目标。经过密集转型项目，目前益普生全球99.8%的电力来自可再生能源。2025年财务指引 益普生为2025财年制定了以下财务指引，其中排除了潜在的后期业务开发交易的任何影响：  以固定汇率计算，总销售额增长超过5.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4620551_ZH20551_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4231","IPN","IPSEY","BK4080","BK4505","ADC","ALGS","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511973346","title":"Aligos Therapeutics, Inc.盘中异动 急速拉升5.43%报22.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511973346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511973346?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:17","pubTimestamp":1739546241,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时17分，Aligos Therapeutics, Inc.股票出现波动，股价大幅上涨5.43%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2358.95%、615.56%、469.87%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231722abcf1100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4139","LENZ","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510204387","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510204387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510204387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284445,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分，Aligos Therapeutics, Inc.股票出现波动，股价急速跳水5.42%。截至发稿，该股报26.20美元/股，成交量6252股，换手率0.17%，振幅2.17%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2013.25%、534.44%、178.65%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Akari Therapeutics Plc，振幅分别为25.06%、21.89%、16.07%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112234059881bd59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALGS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510869362","title":"Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报29.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510869362?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:08","pubTimestamp":1739200110,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时08分，Aligos Therapeutics, Inc.股票出现异动，股价急速拉升5.67%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2375.57%、1451.34%、906.24%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为69.83%、66.09%、39.57%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210230830a240aac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509727462","title":"Aligos Therapeutics, Inc.盘中异动 下午盘快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509727462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509727462?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:26","pubTimestamp":1738952813,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时26分，Aligos Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Conduit Pharmaceuticals Inc.、Sionna Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为7709.99%、175.45%、124.43%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、54.63%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022653961b6048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022653961b6048&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","LENZ","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509204915","title":"Aligos Therapeutics, Inc.盘中异动 大幅上涨5.02%报26.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509204915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509204915?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:34","pubTimestamp":1738863273,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时34分，Aligos Therapeutics, Inc.股票出现异动，股价快速拉升5.02%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6268.65%、1642.41%、164.99%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、58.78%、53.02%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013433961a34a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013433961a34a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4139","BK4505","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509282331","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509282331?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:37","pubTimestamp":1738766255,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时37分，Aligos Therapeutics, Inc.股票出现波动，股价大幅跳水5.11%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3089.14%、800.00%、633.45%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为54.05%、34.67%、23.35%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223735a23a7c7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223735a23a7c7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508380149","title":"Aligos Therapeutics, Inc.盘中异动 急速下挫6.28%报24.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508380149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508380149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593305,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Aligos Therapeutics, Inc.股票出现异动，股价急速下跌6.28%。截至发稿，该股报24.18美元/股，成交量3.1591万股，换手率0.88%，振幅8.49%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为350.34%、300.06%、138.93%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223505a2380a73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223505a2380a73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALGS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aligos.com","stockEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":-0.1474},{"period":"3month","weight":0.1348},{"period":"6month","weight":-0.2118},{"period":"1year","weight":-0.4146},{"period":"ytd","weight":-0.485}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0091},{"period":"3month","weight":0.0116},{"period":"6month","weight":0.0487},{"period":"1year","weight":0.1116},{"period":"ytd","weight":0.1082}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新疗法，以解决肝病和病毒感染方面未满足的医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.020655},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.084797},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.197646},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.12162},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.029634},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.083851},{"month":7,"riseRate":0.5,"avgChangeRate":-0.019227},{"month":8,"riseRate":0.666667,"avgChangeRate":0.159266},{"month":9,"riseRate":0,"avgChangeRate":-0.12835},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.065237},{"month":11,"riseRate":0.666667,"avgChangeRate":0.350449},{"month":12,"riseRate":0.333333,"avgChangeRate":0.114782}],"exchange":"NASDAQ","name":"Aligos Therapeutics, Inc.","nameEN":"Aligos Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aligos Therapeutics, Inc.,ALGS,Aligos Therapeutics, Inc.股票,Aligos Therapeutics, Inc.股票老虎,Aligos Therapeutics, Inc.股票老虎国际,Aligos Therapeutics, Inc.行情,Aligos Therapeutics, Inc.股票行情,Aligos Therapeutics, Inc.股价,Aligos Therapeutics, Inc.股市,Aligos Therapeutics, Inc.股票价格,Aligos Therapeutics, Inc.股票交易,Aligos Therapeutics, Inc.股票购买,Aligos Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}